The Enterprise Value as of December 2025 (TTM) for Elicera Therapeutics AB (publ) (ELIC.ST) is 275.33M

According to Elicera Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 275.33M. This represents a change of 198.77% compared to the average of 92.16M of the last 4 quarters.

Elicera Therapeutics AB (publ) (ELIC.ST) Historical Enterprise Value (quarterly & annually)

How has ELIC.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Elicera Therapeutics AB (publ) over the last ten years is 61.77M. The current 275.33M Enterprise Value has changed 44.48% with respect to the historical average. Over the past ten years (40 quarters), ELIC.ST's Enterprise Value was at its highest in in the June 2025 quarter at 251.07M. The Enterprise Value was at its lowest in in the March 2024 quarter at -9310247.84.

Elicera Therapeutics AB (publ) (ELIC.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Elicera Therapeutics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Elicera Therapeutics AB (publ) (ELIC.ST) Average Enterprise Value

How has ELIC.ST Enterprise Value performed in the past?

The current Enterprise Value of Elicera Therapeutics AB (publ) (ELIC.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Elicera Therapeutics AB (publ) (ELIC.ST) Enterprise Value vs. Peers

How is ELIC.ST’s Enterprise Value compared to its peers?

Elicera Therapeutics AB (publ)’s Enterprise Value is greater than Xintela AB (publ) (175.97M), greater than Intervacc AB (publ) (134.45M), less than Ascelia Pharma AB (publ) (281.46M), less than Acarix AB (publ) (318.96M), greater than Karolinska Development AB (publ) (46.80M), greater than Mendus AB (publ) (224.40M), greater than Bio-Works Technologies AB (publ) (164.97M), less than Nanexa AB (publ) (308.64M), less than Magle Chemoswed Holding AB (publ) (687.67M), greater than Initiator Pharma A/S (144.10M),

Build a custom stock screener for Elicera Therapeutics AB (publ) (ELIC.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elicera Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elicera Therapeutics AB (publ) (ELIC.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elicera Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.